2016
DOI: 10.1016/j.ajog.2015.10.150
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of iatrogenic ureteral injuries during robotic gynecologic surgery: a review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
15
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(16 citation statements)
references
References 33 publications
0
15
0
1
Order By: Relevance
“…The fluorescence can be visualised after approximately 5 min following the injection, lasting over 3 h. Because ICG fluorescence penetrates tissue, the entire course of the ureters can be precisely localised, even when the ureters are embedded in surrounding adipose or fibrotic tissue or are anatomically distorted. [ 36 ] There are two clinically relevant features for intraureteral ICG application, that must be taken into account. First of all, it is not yet approved by the FDA, so the surgeons must disclose that intraureteral ICG is an off-label use.…”
Section: Introductionmentioning
confidence: 99%
“…The fluorescence can be visualised after approximately 5 min following the injection, lasting over 3 h. Because ICG fluorescence penetrates tissue, the entire course of the ureters can be precisely localised, even when the ureters are embedded in surrounding adipose or fibrotic tissue or are anatomically distorted. [ 36 ] There are two clinically relevant features for intraureteral ICG application, that must be taken into account. First of all, it is not yet approved by the FDA, so the surgeons must disclose that intraureteral ICG is an off-label use.…”
Section: Introductionmentioning
confidence: 99%
“…This prevention is made by contrasting these structures (6,10) to blood vessels anatomy and their identification, allowing partial resection of solid organs or anastomosis in better vascularized spots, (6,7) however, the knowledge of this system is still incipient. Most studies published so far are small series or case reports.…”
Section: Introductionmentioning
confidence: 99%
“…One possible drawback of intraureteral injection of ICG is its limitation for use in perfusion assessment due to subsequent low tissue contrast. It is also worth mentioning that the U.S. Food and Drug Administration (FDA) approval of ICG is limited for intravenous use; thus, it is imperative to disclose off-label intraureteral use 19) . Additional fluorescent substances have been studied for that purpose.…”
Section: Intraoperative Ureteral Injury Identificationmentioning
confidence: 99%
“…Subsequent visualization under NIR fluorescence may be used as a means of primary and secondary prevention of IUI. With regards to secondary prevention, full-thickness ureteral injuries cause readily apparent leakage of ICG into the surgical field [18][19][20] . One possible drawback of intraureteral injection of ICG is its limitation for use in perfusion assessment due to subsequent low tissue contrast.…”
Section: Intraoperative Ureteral Injury Identificationmentioning
confidence: 99%